People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arena Pharmaceuticals Inc | — | Biotechnology | Series D+ | $187.3M | $1.5B | 2009 |
PHILLIP M. SCHNEIDER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PHILLIP M. SCHNEIDER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tina S. Nova | 1 | 3 |
| Randall E. Woods | 1 | 2 |
| Robert E. Hoffman | 1 | 2 |
| Christine A. White | 1 | 2 |
| HARRY F. HIXSON, JR. | 1 | 1 |
| DOMINIC P. BEHAN | 1 | 1 |
| J. CLAYBURN LA FORCE, JR. | 1 | 1 |
| K.A. AJIT-SIMH | 1 | 1 |
| SCOTT H. BICE | 1 | 1 |
| WILLIAM R. SHANAHAN, JR. | 1 | 1 |
| DONALD D. BELCHER | 1 | 1 |
| STEVEN W. SPECTOR | 1 | 1 |
| JACK LIEF | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.